Symptomatic pituitary metastases

Journal of Neurosurgery - Tập 89 Số 1 - Trang 69-73 - 1998
Akio Morita1, Fredric B. Meyer2, Edward R. Laws
1Department of Neurological Surgery, George Washington University, Washington DC, USA
2Neurosurgery

Tóm tắt

Object. The diagnosis and treatment of metastasis to the pituitary gland can be difficult to determine. The goal of this study was to analyze the clinical presentation, treatment, and prognosis of patients who presented with symptomatic pituitary metastasis.

Methods. The cases of 36 patients with symptomatic pituitary metastases were reviewed. The most common primary cancers were breast (33%) and lung (36%). The presenting symptoms included diabetes insipidus, anterior pituitary insufficiency, and retroorbital pain. The overall median length of patient survival following diagnosis of pituitary metastasis was 180 days. In 20 patients (56%), symptoms stemming from pituitary metastasis were the first manifestation of illness. Local control of tumor was associated with significant improvement in survival times (p < 0.05) and amelioration of disabling symptoms including painful ophthalmoplegia and visual field deficits.

Conclusions. Aggressive treatment including both surgical decompression and radiation therapy improves the quality of life in patients suffering from symptomatic pituitary metastasis.

Từ khóa


Tài liệu tham khảo

10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7

10.1210/jcem-65-3-469

Buonaguidi R, 1983, Surg Neurol, 20, 373, 10.1016/0090-3019(83)90005-8

Bynke O, 1982, Lancet, 2, 1336, 10.1016/S0140-6736(82)91535-5

Cox EV, 1979, Surg Neurol, 11, 49

de la Monte SM, 1984, Am J Pathol, 114, 131

10.1038/bjc.1957.63

Hägerstrand I, 1969, Acta Pathol Microbiol Scand, 75, 64

Hollenhorst RW, 1973, Diagnosis and Treatment of Pituitary Tumors., 53

10.1002/1097-0142(197009)26:3<656::AID-CNCR2820260325>3.0.CO;2-M

Juneau P, 1992, Arch Neurol, 49, 555, 10.1001/archneur.1992.00530290147025

10.1136/jnnp.48.1.44

10.1002/1097-0142(19831215)52:12<2355::AID-CNCR2820521232>3.0.CO;2-J

10.1159/000224763

Leclercq TA, 1984, R I Med J, 67, 437

Marin F, 1992, Mayo Clin Proc, 67, 949, 10.1016/S0025-6196(12)60925-2

Masse SR, 1973, Arch Pathol, 96, 141

Max MB, 1981, Neurology, 31, 998, 10.1212/WNL.31.8.998

10.1097/00004728-199305000-00018

10.3109/02688698909001028

Molinatti PA, 1985, Arch Pathol Lab Med, 109, 287

Morita A, 1987, Neurol Med Chir, 27, 436, 10.2176/nmc.27.436

10.1097/00006123-198712000-00030

10.1002/1097-0142(197002)25:2<478::AID-CNCR2820250227>3.0.CO;2-X

Takakura K, Sano K, Hojo S, et al:Metastatic Tumors of the Central Nervous System.Tokyo: Igaku-Shoin, 1982, pp 101–104

10.1002/1097-0142(197507)36:1<216::AID-CNCR2820360123>3.0.CO;2-E